Vesugen

Vesugen is a synthetic peptide studied for its potential vascular-regulatory effects. It is derived from DNA-regulating peptide complexes and has been evaluated in Russia for its effects on endothelial function and cardiovascular aging.

• Regulates gene expression of vascular wall endothelial cells
• Supports extracellular matrix remodeling and vascular elasticity
• May stabilize microcirculation and reduce endothelial permeability

• unit: mg

  low dose: 0.5

  frequency: Once daily for 10–20 days

  high dose: 2

  standard dose: 1

  administration route: Subcutaneous (SQ)

• Administer daily for 10–20 days. Repeat cycle every 3–6 months for vascular maintenance or recovery.

common: ["Mild nausea (<5%), occasional headaches (<3%), minor digestive upset (user-reported)"]

warnings: ["Drug interactions with statins/ACE inhibitors untested"]

sequence: Lys-Glu-Asp

half life: Estimated 3–4 hours

degradation: Metabolized by renal and hepatic peptidases

molecular weight: 390.39

molecular formula: C15H26N4O8

tissue specificity: Acts primarily on capillaries, vascular smooth muscle, and endothelial tissues

• Peptides tissue-specifically stimulate cell differentiation during their aging.mechanismPMID 22808515 ↗
• Effect of synthetic peptides on aging of patients with organic brain syndrome.clinicalPMID 26390612 ↗